Repository logo
 

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy

Abstract

Ovarian cancer shows considerable heterogeneity in its sensitivity to chemotherapy both clinically and in vitro. This study tested the hypothesis that the molecular basis of this difference lies within the known resistance mechanisms inherent to these patients' tumours.

Description

Source

Br J Cancer, vol.103(5), pp.656 - 662

Rights statement

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.